Effective tobacco dependence treatment

JAMA

Volumn 288, Issue 14, 2002, Pages 1768-1771

  Fiore, Michael C ^a   Hatsukami, Dorothy K ^c   Baker, Timothy B ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM;

ECONOMIC ASPECT; HEALTH CARE SYSTEM; HUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; TOBACCO DEPENDENCE;

EID: 0037048641     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.14.1768     Document Type: Review

References (31)

1. National Cancer Institute. Population Based Smoking Cessation: Proceedings of a Conference on What Works to Influence Cessation in the General Population. Bethesda, Md: US Dept of Health and Human Services, National Institutes of Health; 2000. NIH publication 00-4892.
2. Houston T, Kaufman NJ. Tobacco control in the 21st century: searching for answers in a sea of change [editorial]. JAMA. 2000;284:752-753.
3. Cigarette smoking among adults-United States, 1999. MMWR Morb Mortal Wkly Rep. 2001;50:869-873.
4. US Department of Health and Human Services. Tracking Healthy People 2010. Washington, DC: US Government Printing Office; 2000.
5. Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence: Clinical Practice Guideline. Rockville, Md: US Dept of Health and Human Services; 2000.
6. Task Force on Community Preventive Services. Introducing the guide to community preventive services. Am J Prev Med. 2000; 18(suppl):1-142.
7. Task Force on Community Preventive Services. Tobacco use prevention and control. Am J Prev Med. 2001;20(suppl):1-88.
8. Irvin JE, Brandon TH. The increasing recalcitrance of smokers in clinical trials. Nicotine Tob Res. 2000; 2:79-84.
9. Rigotti NA, Lee JE, Wechsler H. US college students' use of tobacco products. JAMA. 2000;284: 699-705.
10. Fichtenberg CM, Glantz SA. Association of the California tobacco control program with declines in cigarette consumption and mortality from heart disease. N Engl J Med. 2000;343:1772-1777.
11. Daynard PA, Parmet W, Kelder G, et al. Implications for tobacco control of the multistate tobacco settlement. Am J Public Health. 2001;91:1967-1971.
12. Cigarette smoking before and after an excise tax increase and anti-smoking campaign, Massachusetts, 1990-1996. MMWR Morb Mortal Wkly Rep. 1996;45:996-970.
13. Centers for Disease Control and Prevention. Investment in Tobacco Control: State Highlights-2001. Atlanta, Ga: US Dept of Health and Human Services; 2001.
14. Pronk NP, Goodman MJ, O'Connor PJ, et al. Relationship between modifiable health risks and short-term health care charges. JAMA. 1999;282:2235-2239.
15. Halpern MT, Shikiar R, Rentz AM, et al. Impact of smoking status on workplace absenteeism and productivity. Tob Control. 2001;10:233-238.
16. Robbins AS, Fonseca VP, Chao SY, et al. Short term effects of cigarette smoking on hospitalization and associated lost workdays in a young healthy population. Tob Control. 2000;9:389-396.
17. Jackson FN, Holle RHO. Smoking: perspectives 1985. Prim Care. 1985;12:197-216.
18. A clinical practice guideline for treating tobacco use and dependence. JAMA. 2000;283:3244-3254.
19. France EK, Glasgow RE, Marcus AC. Smoking cessation interventions among hospitalized patients: what have we learned? Prev Med. 2001;32:376-388.
20. Centers for Disease Control and Prevention. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Ga: US Dept of Health and Human Services; 2000.
21. Rimer B, Orleans C, Keintz M, et al. The older smoker: status, challenges and opportunities for intervention. Chest. 1990;97:225-229.
22. National Cancer Institute. Risks Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Bethesda, Md: US Dept of Health and Human Services, National Institutes of Health; 2001. NIH publication 02-5074.
23. Centers for Disease Control and Prevention. Preventing Tobacco Use Among Young People: A Report of the Surgeon General. Atlanta, Ga: US Dept of Health and Human Services; 1994.
24. DiFranza JR, Rigotti NA, McNeill AD, et al. Initial symptoms of nicotine dependence in adolescents. Tob Control. 2000;9:313-319.
25. Piasecki TM, Fiore MC, Baker TB. Profiles in discouragement: two studies of variability in the time course of smoking withdrawal. J Abnorm Psychol. 1998;107:238-251.
26. Hays JT, Hurt RD, Rigotti NA, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. Ann Intern Med. 2001; 135:423-433.
27. Stratton K, Shetty P, Wallace R, Bondurant S, eds. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: National Academy Press; 2001.
28. Curry SJ, Grothaus LC, McAfee T, et al. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med. 1998;339:673-679.
29. Moskowitz JM, Lin Z, Hudes ES. The impact of workplace smoking ordinances in California on smoking cessation. Am J Public Health. 2000;90:757-761.
30. Owen L. Impact of a telephone helpline for smokers who called during a mass media campaign. Tob Control. 2000;9:148-154.
31. Decline in cigarette consumption following implementation of comprehensive tobacco prevention and education program-Oregon, 1996-1998. MMWR Morb Mortal Wkly Rep. 1999;48:140-143.